Olaplex Holdings, Inc. to Report First Quarter Fiscal 2024 Financial Results on May 2nd
April 18, 2024 07:45 ET
|
Olaplex Holdings, Inc.
NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (“OLAPLEX”), today announced that it plans to report first quarter fiscal 2024 financial results before the market opens on...
JD.com Announces Updates of Its Share Repurchase Program
April 18, 2024 07:30 ET
|
JD.com, Inc.
BEIJING, April 18, 2024 (GLOBE NEWSWIRE) -- JD.com, Inc. (“JD.com” or the “Company”) (NASDAQ: JD and HKEX: 9618 (HKD counter) and 89618 (RMB counter)), a leading supply chain-based technology and...
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study
April 18, 2024 07:30 ET
|
Benitec Biopharma Inc.
-First efficacy signals demonstrated for a gene therapy under development for Oculopharyngeal Muscular Dystrophy (OPMD) which affects ~15,000 patients worldwide- - BB-301 facilitated improvements...
TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
April 18, 2024 07:30 ET
|
TG Therapeutics, Inc.
NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced two additional data presentations from the ULTIMATE I & II Phase 3 trials evaluating...
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
April 18, 2024 07:30 ET
|
OptimizeRx Corporation
WALTHAM, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and...
Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
April 18, 2024 07:30 ET
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a...
JD.com Files Its Annual Report on Form 20-F
April 18, 2024 07:15 ET
|
JD.com, Inc.
BEIJING, April 18, 2024 (GLOBE NEWSWIRE) -- JD.com, Inc. (“JD.com” or the “Company”) (NASDAQ: JD and HKEX: 9618 (HKD counter) and 89618 (RMB counter)), a leading supply chain-based technology and...
The Joint Corp. to Host Conference Call on Thursday, May 2nd to Discuss First Quarter 2024 Results
April 18, 2024 07:05 ET
|
The Joint Corp.
SCOTTSDALE, Ariz., April 18, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced it...
Mawson Infrastructure Group Inc. Announces Monthly Operational Update for March 2024
April 18, 2024 07:00 ET
|
Mawson Infrastructure Group Inc.
Mawson Infrastructure Group Inc. Announces Monthly Operational Update for March 2024
SpringWorks Therapeutics to Report First Quarter 2024 Financial Results Thursday, May 2, 2024
April 18, 2024 07:00 ET
|
SpringWorks Therapeutics, Inc.
STAMFORD, Conn., April 18, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today...